Citizens National Bank Trust Department Trims Position in UnitedHealth Group Incorporated (NYSE:UNH)

Citizens National Bank Trust Department lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 17,716 shares of the healthcare conglomerate’s stock after selling 73 shares during the quarter. UnitedHealth Group makes up about 1.9% of Citizens National Bank Trust Department’s investment portfolio, making the stock its 10th largest holding. Citizens National Bank Trust Department’s holdings in UnitedHealth Group were worth $8,962,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the stock. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter worth about $30,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group in the 3rd quarter worth $37,000. DecisionPoint Financial LLC boosted its stake in UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the period. Highline Wealth Partners LLC bought a new position in UnitedHealth Group during the third quarter valued at approximately $55,000. Finally, Legacy Investment Solutions LLC bought a new stake in UnitedHealth Group in the third quarter worth $57,000. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

UNH has been the subject of a number of analyst reports. Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Stephens raised their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Finally, Barclays decreased their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 2.0 %

NYSE:UNH opened at $510.75 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The stock’s 50 day moving average price is $520.62 and its 200 day moving average price is $561.67. The company has a market capitalization of $470.03 billion, a P/E ratio of 32.95, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the business posted $5.83 earnings per share. The company’s revenue was up 6.8% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.